Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efavirenz vs Nevirapine in HIV/TB Co-infected Patients on Rifampin
NCT00483054Phase 3Completed
- Sponsor
- Bamrasnaradura Infectious Diseases Institute
- Start
- Jan 2007
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in human immunodeficiency virus infection (HIV) comparing Efavirenz with Nevirapine (2 arms). Primary endpoint: Proportion of patients who achieved undetectable plasma HIV-1 RNA < 50 copies/mL at 48 weeks. Started Jan 2007; status: completed.
02
Drugs
efavirenznevirapine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00483054.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00483054.